logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

The problem of demarcation of systemic effects and concomitant diseases in patients with chronic obstructive pulmonary disease

[Reviews]
Tatiana Zhdanov; Larisa Maslova; Elena Selezneva;

The presence of pulmonary and systemic symptoms, including cardiovascular pathology, polycythemia or anemia, weight loss and so on, is essential for chronic obstructive pulmonary disease (COPD). The pathogenesis of COPD based on neurohormonal dysregulation, chronic hypoxemia and inflammation. Dysfunction of the renin-angiotensin-aldosterone system induces development of arterial hypertension, left and right ventricular insufficiency, impacts hematocrit. There is a pathogenetic link between the described systemic effects of COPD. It is important to distinquish the symptoms of comorbid pathology and signs of COPD.

Download

References:
1. Vertkin A. L., Rumyantsev M. A., Skotnikov A. S. Klinicheskaya meditsina. – Сlinical medicine. 2012;10:4-11.
2. Dvoretsky L. I. Pulmonologiya. – Рulmonology. 2012;2:5-11.
3. Minayev S. V., Isayeva A. V., Obedin A. N., Bolotov Yu. N., BochnyukYe.A., Chintayeva L.A., Gudiyev Ch. G. Meditsinsky vestnik Severnogo Kavkaza. – Medical news of North Caucasus. 2011;2:95-99.
4. Nikolayeva L. A., Kirsanov A. I., Gorbacheva I. A., Yegorova L. P., Sycheva Yu.A. Nefrologiya. – Nephrology. 2009;3:78.
5. Rossyskoye respiratornoye obshchestvo. Federalnye klinicheskiye rekomendatsii po diagnostike i lecheniyu khronicheskoy obstruktivnoy bolezni legkikh. Moskva: «Rossyskoye respiratornoye obshchestvo»; 2013. Р. 1-41.
6. Trifonova O. Yu. Neyrogumoralnye mekhanizmy initsiatsii, stanovleniya i progressirovaniya arterialnoy gipertenzii: avtoref. dis. d-ra med. nauk. Tomsk; 2004. 54 р.
7. Chereshnev V. A., Gusev Ye. Yu.,Yurchenko L. N. Vestnik Rossyskoy akademii nauk. – News of the Russian Academy of Sciences. 2004;3:219-227.
8. Аgusti A. G. Proc. Am. Thorac. Soc. 2007;4:522-525.
9. Arestegui A. Н., Fuquay R., Sirota J., Swenson E. R., Schoene R. B., Jefferson J. A., Chen W., Yu X., Kelly J.P., Johnson R.J., Escudero E. J. Am. Soc. Nephrol. 2011;22:1963-1968.
10. Attaran D., Khajedalouee M., Ahmadi F., Rezaeitalab F., Towhidi M., Asnaashari A., Babaeian M., Rezaei S., Lari S. M. Tanaffos. 2009;8(2):11-16.
11. Auffray C., Adcock I. M., Chung K. F., Djukanovic R., Pison C., Sterk P.J. Chest. 2010;137(6):1410-1416.
12. Barnes P. J., Celli B. R. Eur. Respir. J. 2009;33(5):1165-1185.
13. Bayley D. L., Abusriwil H., Ahmad A., Stockley R. A. Eur. Respir. J. 2008;31(5):943-948.
14. Becker K. L., Snider R., Nylen E. S. Br. J. Pharmacol. 2010;159(2):253-264.
15. Beghé B., Verduri A., Roca M., Fabbri L. M. Eur. Respir J. 2013;41(4):993-995.
16. Berry C. E., Wise R. A. COPD. 2010;7:375-378.
17. Celli B.R., MacNee W. Eur. Respir. J. 2004;23:932-946.
18. Chambellan A., Coulon S., Cavailles A., Hermine O., Similowski T. Rev. Mal. Respir. 2012;29:213-231.
19. Cookson W.O., Moffatt M.F. Proc. Am. Thorac. Soc. 2011;8(2):149-153.
20. Dahl M., Vestbo J., Zacho J., Lange P.,Tybjærg-Hansen A., Nordestgaard B.G. Thorax. 2011;66(3):197-204.
21. Dawkins P. A., Dawkins C. L., Wood A. M., Nightingale P. G., Stockley J. A., Stockley R. A. Eur. Respir. J. 2009;33(6):1338-1344.
22. Dirksen A., Piitulainen E., Parr D. G., Piitulainen E., Deng C., Wencker M., Stockley R. A. Eur. Respir. J. 2009;33(6):1345-1353.
23. Donaldson G. C., Wedzicha J. A. Thorax. 2006;61(2):164-168.
24. Duvoix A., Dickens J., Haq I., Mannino D., Miller B., Tal-Singer R., Lomas D. A. Thorax. 2013; 68(7):670-676.
25. Falsey A. R., Becker K. L., Swinburne A. J., Falsey A. R., Becker K. L., Swinburn A. J., Nylen E. S., Snider R. H., Formica M. A., Hennessey P. A., Criddle M. M., Peterson D. R., Walsh E.E. Int. J. Chron. Obstruct. Pulmon. Dis. 2012;7:127-135.
26. Fischer B. M., Pavlisko E., Voynow J. A. Int. J. Chron. Obstruct. Pulmon. Dis. 2011;6: 413-421.
27. Galbán C. J., Han M. K., Boes J. L., Chughtai K. A., Meyer C. R., Johnson T. D., Galban S., Rehemtulla A., Kazerooni E. A., Martinez F.J., Ross B.D. Nat. Med. 2012;18(11):1711-1715.
28. Gregori M., Tocci G., Giammarioli B., Befani A., Ciavarella G. M., Ferrucci A., PaneniF. Journal of Cardiology. 2014;30:188-194.
29. Gregori M., Tocci G., Marra A., Pignatelli G., Santolamazza C., Befani A., Ciavarella G. M., Ferrucci A., Paneni F. Clin. Res. Cardiol. 2013;102:725-733.
30. Gregori M., Tocci G., Befani A., Ciavarella G. M., Ferrucci A., Paneni F. Int. J. Cardiol. 2013;168:4934-4936.
31. Groenewegen K. H., Postma D. S., Hop W. C., Wielders P. L., Schlosser N. J., Wouters E. F. Chest. 2008;133:350-357.
32. Guerra S., Sherrill D.L., Venker C., Ceccato C. M., Halonen M., Martinez F. D. Thorax. 2009;64(10):894-900.
33. Han M. K., Agusti A., Calverley P. M., Celli B. R., Criner G., Curtis J. L., Fabbri L. M., Goldin J. G., Jones P. W., Macnee W., Make B. J., Rabe K. F., Rennard S. I., Sciurba F. C., Silverman E. K., Vestbo J., Washko G. R., Wouters E. F., Martinez F. J. Am. J. Respir. Crit. Care Med. 2010;182:598-604.
34. Haruna A., Muro S., Nakano Y., Ohara T., Hoshino Y., Ogawa E., Hirai T., Niimi A., Nishimura K., Chin K., Mishima M. Chest. 2010;138(3):635-640.
35. Haznedaroglu I. C., Beyazit Y. Clin. Sci. (Lond). 2013;124(5):307-323.
36. He J. Q., Foreman M. G., Shumansky K. Thorax. 2009;64:698-704.
37. Jokubaitis V. J., Sinka L., Driessen R., Whitty G., Haylock D. N., Bertoncello I., Smith I., Peault B.,Tavian M., Simmons P. J. Blood. 2008;111(8):4055-4063.
38. Jones P.W. COPD. 2009;6(1):59-63.
39. Kent B. D., Mitchell P. D., McNicholas W. T. Int. J. Chron. Obstruct. Pulmon. Dis. 2011;6:199-208.
40. Kirkham P. A., Barnes P. J. Chest. 2013;144(1):266-273.
41. Liu H. W., Cheng B., Li J. F., Wu H. J., Li K. Y., Sun T. Z., Fu X. B. Br. J. Dermatol. 2009;160(2):250-258.
42. Lundby C., Olsen N.V. J. Physiol. 2011;589:1265-1271.
43. Matsushita K., Wu Y., Okamoto Y., Pratt R. E., Dzau V.J. Hypertension. 2006;48(6):1095-1102.
44. Morrissey R. P., Czer L., Shah P. K. Am. J. Cardiovasc. Drugs. 2011;11:153-171.
45. Savary K., Michaud A., Favier J., Larger E., Corvol P., Gasc J. M. Blood. 2005;105(1):103-110.
46. Shen X. Z., Bernstein K. E. Cell Cycle. 2011;10:1363-1369.
47. Sinka L., Biasch K., Khazaal I., Péault B., Tavian M. Blood. 2012;119(16):3712-3723.
48. Tavian M., Biasch K., Sinka L., Vallet J., Péault B. Int. J. Dev. Biol. 2010;54(6-7):1061-1065.
49. Vlahakos D.V., Marathias K.P., Madias N.E. Am. J. Kidney Dis. 2010;56:558-565.
50. Vlahakos D. V., Marathias K. P., Agroyannis B., Madias N. E. Kidney Int. 2003;63:1187-1194.
51. Wang H., Gomez J. A., Klein S., Zhang Z., Seidler B., Yang Y., Schmeckpeper J., Zhang L., Muramoto G. G., Chute J., Pratt R. E., Saur D., Mirotsou M., Dzau V. J. J. Am. Soc. Nephrol. 2013;24(8):1263-1273.
52. Zambidis E. T., Park T. S., Yu W., Tam A., Levine M., Yuan X., Pryzhkova M., Peault B. Blood. 2008;112(9):3601-3614.
53. Zhou X. J., Vaziri N. D. Nephrol. Dial. Transplant. 2009;24:1082-1088.

Keywords: neurohumoral regulation, systemic effects, erythrocytosis, hypertension, chronic obstructive pulmonary disease


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy